Walbrook PR – ILC Therapeutics
01 August 2023
Walbrook PR, which provides high quality Strategic communications and Investor Relations support to Small and AIM listed companies, announces it is acting as corporate communications advisor for ILC Therapeutics, a Scottish based biotechnology company developing an exciting novel drug class.